Delivering a new treatment pathway with perioperative pembrolizumab for resectable locally advanced oral cancer
- 7 July 2026
- journal article
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 64 (8) , 619-622
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2025
- Immunotherapy for locally advanced head and neck cancerBritish Journal of Oral and Maxillofacial Surgery, 2025
- NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.Journal of Clinical Oncology, 2025